The role of short-chain fatty acids in microbiota–gut–brain communication

B Dalile, L Van Oudenhove, B Vervliet… - Nature reviews …, 2019 - nature.com
Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of
dietary fibre in the gastrointestinal tract, are speculated to have a key role in microbiota–gut …

Melatonin and inflammation—Story of a double‐edged blade

R Hardeland - Journal of pineal research, 2018 - Wiley Online Library
Melatonin is an immune modulator that displays both pro‐and anti‐inflammatory properties.
Proinflammatory actions, which are well documented by many studies in isolated cells or …

Relationship between amyloid-β deposition and blood–brain barrier dysfunction in Alzheimer's disease

D Wang, F Chen, Z Han, Z Yin, X Ge… - Frontiers in Cellular …, 2021 - frontiersin.org
Amyloid-β (Aβ) is the predominant pathologic protein in Alzheimer's disease (AD). The
production and deposition of Aβ are important factors affecting AD progression and …

Role of the blood-brain barrier in central nervous system insulin resistance

EM Rhea, WA Banks - Frontiers in neuroscience, 2019 - frontiersin.org
The blood-brain barrier (BBB) mediates the communication between the periphery and the
central nervous system (CNS). Recently, CNS insulin resistance has been elucidated to play …

State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease

EM Rhea, M Leclerc, HN Yassine… - Aging and …, 2024 - pmc.ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is common and increasing in prevalence worldwide, with
devastating public health consequences. While peripheral insulin resistance is a key feature …

Network-driven anomalous transport is a fundamental component of brain microvascular dysfunction

F Goirand, T Le Borgne, S Lorthois - Nature communications, 2021 - nature.com
Blood microcirculation supplies neurons with oxygen and nutrients, and contributes to
clearing their neurotoxic waste, through a dense capillary network connected to larger tree …

[HTML][HTML] True or False? Alzheimer's disease is Type 3 Diabetes: Evidences from Bench to Bedside.

Y Peng, S Yao, Q Chen, H Jin, M Du, Y Xue… - Ageing research reviews, 2024 - Elsevier
Globally, Alzheimer's disease (AD) is the most widespread chronic neurodegenerative
disorder, leading to cognitive impairment, such as aphasia and agnosia, as well as mental …

Cognitive dysfunction: a growing link between diabetes and Alzheimer's disease

K Jash, P Gondaliya, P Kirave… - Drug development …, 2020 - Wiley Online Library
Diabetes mellitus (DM) is a gradually rising metabolic disease which is currently affecting
millions of people worldwide. Diabetes is associated with various complications like …

How can insulin resistance cause Alzheimer's disease?

JH Yoon, JH Hwang, SU Son, J Choi, SW You… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a neurodegenerative disorder associated with cognitive decline.
Despite worldwide efforts to find a cure, no proper treatment has been developed yet, and …

[HTML][HTML] Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro …

CC Gali, E Fanaee-Danesh, M Zandl-Lang… - Molecular and Cellular …, 2019 - Elsevier
Aberrant insulin signaling constitutes an early change in Alzheimer's disease (AD). Insulin
receptors (IR) and low-density lipoprotein receptor-related protein-1 (LRP-1) are expressed …